Skip to Main Content

Try STAT+ TODAY

Theranos

Most Read

Bakul Patel

Health Tech By Casey Ross

Google taps FDA’s former digital health chief for global strategy role

cytokine storm cell signalling

Health By Jason Mast

FDA rejects antidepressant seen as possible Covid-19 treatment

Benjamins

Biotech By Allison DeAngelis

Apollo acquires minority stake in Sofinnova, extending private equity dealmaking in life sciences

By STAT

The need for speed and safety: A primer on the FDA’s drug approval pathways

Bribery

Pharmalot By Ed Silverman

Greece plans to go to court to seek compensation from Novartis over a bribery scandal

Pharmalot By Ed Silverman

Pharmalittle: FDA OKs new type of diabetes drug from Lilly; Early-stage biotechs are juicy targets for M&A surge

Biotech By Damian Garde

Seagen CEO resigns after arrest on domestic assault charges

Daughter mother hands end-of-life care

First Opinion By Shoshana Ungerleider

One million reasons to reimagine end-of-life care

All Coverage

Theranos

Biotech By Meghana Keshavan

Theranos tries to quell doubts with new blood test platform, but shows scant data

Elizabeth Holmes

Biotech By Meghana Keshavan

Embattled Theranos promises first-ever peek at its science — but doubts abound

advertisement

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Biogen CEO to leave, Theranos hires compliance execs

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Purdue delayed reporting excessive OxyContin prescribing

Elizabeth Holmes Theranos

Biotech By Megan Thielking

Theranos CEO Elizabeth Holmes banned for two years from industry she aimed to transform

Verily Tech

Special Report By Charles Piller

‘Silicon Valley arrogance’? Google misfires as it strives to turn Star Trek fiction into reality

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Odds of an early-stage biotech drug winning approval are slim

Elizabeth Holmes at the 2016 Breakthrough Prize ceremony.

Business By Rebecca Robbins

Theranos faces lawsuit alleging it falsely marketed blood tests

Elizabeth Holmes - Theranos

Business By Rebecca Robbins and Meghana Keshavan

Theranos plans bold expansion even as it reels from new setbacks

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: UK refuses to cover Bristol lung cancer drug

Elizabeth Holmes - Theranos

Politics By Rebecca Robbins

When does hyping a product become a criminal act? Theranos may be about to find out

Elizabeth Holmes

Business By Rebecca Robbins

Theranos CEO Elizabeth Holmes says she’s ‘devastated’ by setbacks

Business By Rebecca Robbins

Theranos CEO Elizabeth Holmes faces possible two-year ban from blood-testing industry

Theranos

First Opinion By Steve Brozak

Theranos debacle may scare investors away from diagnostic technology

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Sanofi poaches a top scientist from AstraZeneca

Politics By Ed Silverman

Avoiding ‘teapot tempest,’ Clinton campaign distances itself from Theranos

Clinton & Holmes

Politics By David Nather

What Theranos has to lose by hosting a Hillary Clinton fundraiser

Elizabeth Holmes

Politics By Eric Boodman

Beleaguered Theranos CEO to hold fundraiser for Hillary Clinton

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Walgreens threatens to terminate Theranos partnership

Elizabeth Holmes Theranos

Business By Rebecca Robbins

Is Theranos finished? Watch for these 5 telltale signs

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Roche internal investigation, problems at Theranos lab

Elizabeth Holmes Theranos

Business By Rebecca Robbins

The Theranos scandal should be a wake-up call. Here are 4 reasons it won’t be

3 to Watch: Silicon Valley

Business By Charles Piller

3 people to watch in Silicon Valley in 2016

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: US prices higher for top-selling drugs, FDA investigating Theranos

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Drug makers pay up for fraud, false claims